Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 23
2021
|
Heisz Leslie Stone Director |
SELL
Open market or private sale
|
Direct |
6,707
-22.91%
|
$650,579
$97.52 P/Share
|
|
Apr 23
2021
|
Heisz Leslie Stone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.46%
|
$350,000
$35.68 P/Share
|
|
Apr 23
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Open market or private sale
|
Indirect |
12,000
-37.03%
|
$1,164,000
$97.66 P/Share
|
|
Apr 22
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.16%
|
$318,566
$94.4 P/Share
|
|
Apr 22
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.04%
|
$74,558
$22.29 P/Share
|
|
Apr 12
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.11%
|
$665,550
$85.84 P/Share
|
|
Apr 12
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.06%
|
$274,050
$35.2 P/Share
|
|
Apr 09
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-21.12%
|
$1,098,468
$84.27 P/Share
|
|
Apr 09
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.44%
|
$170,001
$13.98 P/Share
|
|
Apr 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.36%
|
$533,400
$84.88 P/Share
|
|
Apr 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.98%
|
$133,350
$21.76 P/Share
|
|
Apr 08
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+0.99%
|
-
|
|
Apr 08
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-24.5%
|
$5,758,200
$84.45 P/Share
|
|
Apr 08
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-9.68%
|
-
|
|
Apr 08
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Apr 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
13,020
-8.53%
|
$1,080,660
$83.66 P/Share
|
|
Apr 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
13,020
+7.86%
|
$169,260
$13.98 P/Share
|
|
Mar 15
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.25%
|
$274,509
$81.66 P/Share
|
|
Mar 15
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.11%
|
$74,558
$22.29 P/Share
|
|
Mar 12
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-21.23%
|
$1,072,314
$82.85 P/Share
|
|
Mar 12
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.52%
|
$170,001
$13.98 P/Share
|
|
Mar 09
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.0%
|
-
|
|
Mar 09
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-8.4%
|
$5,621,100
$82.35 P/Share
|
|
Mar 09
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-10.7%
|
-
|
|
Mar 09
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Mar 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.38%
|
$514,350
$81.37 P/Share
|
|
Mar 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+6.0%
|
$133,350
$21.76 P/Share
|
|
Mar 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
13,020
-4.35%
|
$1,093,680
$84.85 P/Share
|
|
Mar 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
13,020
+7.88%
|
$169,260
$13.98 P/Share
|
|
Mar 01
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.11%
|
$649,890
$83.99 P/Share
|
|
Mar 01
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.07%
|
$274,050
$35.2 P/Share
|
|
Feb 23
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.01%
|
-
|
|
Feb 23
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-12.44%
|
-
|
|
Feb 23
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-5.97%
|
$5,758,200
$84.46 P/Share
|
|
Feb 23
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Feb 16
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.25%
|
$298,232
$88.2 P/Share
|
|
Feb 16
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.11%
|
$74,558
$22.29 P/Share
|
|
Feb 11
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,745
-11.19%
|
$1,010,070
$86.81 P/Share
|
|
Feb 11
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,661
+10.0%
|
$151,593
$13.98 P/Share
|
|
Feb 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-21.23%
|
$1,111,545
$85.8 P/Share
|
|
Feb 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.52%
|
$170,001
$13.98 P/Share
|
|
Feb 04
2021
|
Nicholas J Valeriani Director |
SELL
Open market or private sale
|
Direct |
8,200
-12.08%
|
$697,000
$85.21 P/Share
|
|
Feb 04
2021
|
Nicholas J Valeriani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,608
+24.98%
|
$452,160
$20.76 P/Share
|
|
Feb 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
20,523
-12.85%
|
$1,703,409
$83.51 P/Share
|
|
Feb 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
20,523
+6.18%
|
$246,276
$12.67 P/Share
|
|
Jan 15
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.25%
|
$294,843
$87.27 P/Share
|
|
Jan 15
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.11%
|
$74,558
$22.29 P/Share
|
|
Jan 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,730
-11.17%
|
$1,020,510
$87.27 P/Share
|
|
Jan 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,649
+9.98%
|
$151,437
$13.98 P/Share
|
|
Jan 15
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.02%
|
-
|